Project Details
Projekt Print View

Role of cannabinoid system in systemic and brain ageing

Subject Area Molecular Biology and Physiology of Neurons and Glial Cells
Term from 2019 to 2023
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 426320013
 
Final Report Year 2024

Final Report Abstract

Mice with constitutive or conditional deletion of the cannabinoid receptor type 1 (CB1) showed accelerated brain ageing and early onset of several symptoms of physical ageing. Increased CB1 receptor activity improved learning and memory functions, and restored synapse density and gene expression profiles in the brains of old individuals to those of young individuals. All these findings suggest that the activity of the cannabinoid system influences the ageing process. However, it was not known whether CB1 receptor activity exerts its anti-aging effect locally or systematically. Our present work has shown that animals with hippocampus-specific deletion have a similar memory deficit and neuroinflammation as the conditional knockout animals. Hypothalamus-specific deletion of CB1 receptors led to neuroinflammation and impaired insulin-like growth factor signalling in the hypothalamus without histological evidence of altered physical ageing. These results now show that 1. local CB1 receptor activity is responsible for regulating glial inflammatory activity and thus ageing in the brain. 2. Hypothalamic CB1 receptor activity and the resulting neuroinflammation per se do not significantly influence physical ageing. Finally, we reported that chronic lowdose treatment with tetrahydrocannabinol alone was more effective in improving learning in aged mice than the 1:1 combination of tetrahydrocannabinol and cannabidiol. This finding is important for the design of clinical trials to test the antiageing effects of cannabis derivatives.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung